Trial
NCT01578343
Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Samsung Medical Center
Collaborators
Seok Jin Kim
Condition
Mantle Cell Lymphoma
Intervention
Fludarabine, Mitoxantrone, Dexamethasone, Vorinostat
Why stopped
we collected data of a total of 19 patients for an interim analysis. but there are less than 7 responses out of the initial 19 patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-04-15